文献速递神经MR

对比增强T1容积涡轮自旋回波与梯度回波MR序列检测脑转移瘤:系统综述与Meta分析

Volumetric Postcontrast T1 Turbo Spin-Echo vs Gradient-Recalled Echo MR Sequences for Detecting Brain Metastases: A Systematic Review and Meta-Analysis.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-10-01

该系统综述与Meta分析纳入15项研究共544例患者4338个脑转移瘤,比较对比增强3D T1 TSE与GRE序列检测脑转移瘤的诊断效能;TSE汇总敏感度为97.4%,GRE为76.1%,对比OR为12.0,<5 mm小病灶TSE检测率96.1%高于GRE的58.4%,但TSE假阳性更多,多与血管抑制不完全有关。

要点

  • 对比增强3D T1 TSE检测脑转移瘤的汇总敏感度为97.4%,GRE为76.1%,对比OR为12.0(95% CI,5.45-26.6;P < .0001)。
  • TSE对<5 mm小转移瘤的检测率为96.1%,GRE为58.4%;≥5 mm病灶两者检测率相近(TSE 98.2%,GRE 94.4%)。
  • TSE假阳性更多,主要与血管抑制不完全有关(TSE 49个假阳性计数,GRE 35个)。

核心结论

  • 对比增强3D T1 TSE序列较GRE序列检测脑转移瘤敏感度更高、病灶显示更清晰,尤其对<5 mm小转移瘤,但假阳性略多。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE、Cochrane Central、Google Scholar和PROSPERO自建库至2025年4月,纳入15项研究共544例患者4338个脑转移瘤,采用随机效应模型计算汇总敏感度与对比OR,用QUADAS-2和QUADAS-C评估偏倚风险。

关键影像表现/征象

  • 对比增强3D T1 TSE序列对脑转移瘤的汇总敏感度为97.4%(95% CI,93.2%-99.0%),GRE序列为76.1%(95% CI,69.3%-81.9%)。
  • TSE对<5 mm转移瘤的检测率为96.1%(95% CI,87.7%-98.8%),GRE为58.4%(95% CI,47.9%-68.2%)。
  • 对≥5 mm转移瘤,TSE检测率为98.2%,GRE为94.4%,两者表现相近。
  • TSE的对比噪声比和阅片者间一致性略高于GRE。
  • TSE假阳性更常见,主要与血管抑制不完全有关,TSE假阳性计数49个,GRE为35个。

诊断标准与关键数值

  • TSE检测脑转移瘤的汇总敏感度为97.4%(95% CI,93.2%-99.0%),GRE为76.1%(95% CI,69.3%-81.9%)。
  • TSE vs GRE检测脑转移瘤的对比OR为12.0(95% CI,5.45-26.6;P < .0001)。
  • <5 mm转移瘤检测的OR为17.2(95% CI,4.50-66.1),≥5 mm转移瘤检测的OR为2.81(95% CI,0.92-8.56)。

临床应用与阅片要点

  • 原文指出,对比增强3D T1 TSE序列较GRE序列检测脑转移瘤敏感度更高、病灶显示更清晰,尤其对<5 mm小转移瘤;阅片时需注意TSE假阳性更多,主要与血管抑制不完全有关。

局限性

  • 原文指出本Meta分析存在高异质性。
  • 原文指出纳入研究为仅纳入病例的研究(case-only studies)。
  • 原文指出可能存在小样本研究效应(small-study effects)。
  • 原文指出参考标准领域偏倚风险高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Contrast-enhanced 3D T1-weighted MRI is the imaging reference for detection and follow-up of brain metastases. Volumetric GRE-based sequences, such as MPRAGE, are widely used but remain prone to susceptibility and lower lesion conspicuity. 3D black-blood TSE-based sequences, such as sampling perfection with application-optimized contrasts by using different flip angle evolutions (SPACE), have been increasingly embedded into routine workflow and are thought to improve lesion detection in part through vessel signal suppression.

PURPOSE: We aimed to investigate the comparative diagnostic performance of 3D T1 TSE vs GRE sequences for the detection of brain metastases.

DATA SOURCES: Studies comparing the diagnostic performance of postcontrast 3D T1 TSE and GRE sequences in adults with brain metastases were searched on MEDLINE, EMBASE, Cochrane Central, Google Scholar, and PROSPERO, from inception through April 2025.

STUDY SELECTION: Fifteen studies encompassing 544 patients with 4338 metastases were included.

DATA ANALYSIS: Data on diagnostic accuracy parameters, image quality, and interrater agreement were extracted. Random-effects models were applied to compute pooled sensitivity and comparative OR for lesion detection. Risk of bias was assessed using QUADAS-2 and QUADAS-C tools.

DATA SYNTHESIS: Pooled sensitivities for detection of brain metastases were 97.4% (95% CI, 93.2%-99.0%) for TSE- and 76.1% (95% CI, 69.3-81.9) for GRE-based sequences, with a comparative OR of 12.0 (95% CI, 5.45-26.6; P < .0001). Detectability of small lesions (<5 mm) was significantly better on TSE (96.1%; 95% CI, 87.7-98.8) than GRE (58.4%; 95% CI, 47.9-68.2), although both techniques performed comparably for larger (≥5 mm) lesions (98.2% for TSE, 94.4% for GRE). OR estimates were 17.2 (95% CI, 4.50-66.1) for small and 2.81 (95% CI, 0.92-8.56) for large lesions. Contrast-to-noise ratio and interrater agreements were slightly higher on TSE than GRE. False-positives (FPs) were more common with TSE, mostly related to incomplete vessel suppression (49 FP counts in TSE, 35 in GRE).

LIMITATIONS: Our meta-analysis is limited by high heterogeneity, case-only studies, possible small-study effects, and high risk of bias for the reference standard domain.

CONCLUSIONS: Postcontrast 3D T1 TSE sequences provide higher sensitivity and improved lesion conspicuity compared with GRE sequences, particularly for small metastases, although at the cost of slightly higher FPs.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Benomar A, Ghumman SS, Ouahdi Y, et al. Volumetric Postcontrast T1 Turbo Spin-Echo vs Gradient-Recalled Echo MR Sequences for Detecting Brain Metastases: A Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol. 2026. PMID: 41819794. doi:10.3174/ajnr.A9294

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。